Brenda D. Jamerson, PharmD: Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression

Name: Brenda D. Jamerson, PharmD: Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression
SKU: 2991
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 37 No. 2 Articles Tags: alok-krishen, antidepressants, brenda-d-jamerson, chb, domains, jack-g-modell, jeremy-roberts, k-ranga-rama-krishnan, pharmd, principal-component-analysis, psychometrics, symptom-clusters

Description

Brenda D. Jamerson, PharmD: Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression

Description

Brenda D. Jamerson, PharmD

EVIDENCE-BASED MEDICINE

Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression

Brenda D. Jamerson, PharmD, K. Ranga Rama Krishnan, MB, ChB, Jeremy Roberts, MS, Alok Krishen, MSc, MS, and Jack G. Modell, MD

Generalized Anxiety Disorder: Raising the Expectations of Treatment

Paolo Castrogiovanni, MD: Can Serotonin and Fluoxetine Levels in Plasma and Platelets Predict Clinical Response in Depression?

New Developments in the Neurobiological Basis of Anxiety Disorders

Efficacy of Duloxetine for the Treatment of Depression: Relationship to Most Recent Antidepressant Trial

Brenda D. Jamerson, PharmD: Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression

Description

Brenda D. Jamerson, PharmD

EVIDENCE-BASED MEDICINE

Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression

Brenda D. Jamerson, PharmD, K. Ranga Rama Krishnan, MB, ChB, Jeremy Roberts, MS, Alok Krishen, MSc, MS, and Jack G. Modell, MD

Related products

Generalized Anxiety Disorder: Raising the Expectations of Treatment

Paolo Castrogiovanni, MD: Can Serotonin and Fluoxetine Levels in Plasma and Platelets Predict Clinical Response in Depression?

New Developments in the Neurobiological Basis of Anxiety Disorders

Efficacy of Duloxetine for the Treatment of Depression: Relationship to Most Recent Antidepressant Trial